scispace - formally typeset
C

Claire Duvallet

Researcher at Massachusetts Institute of Technology

Publications -  51
Citations -  12879

Claire Duvallet is an academic researcher from Massachusetts Institute of Technology. The author has contributed to research in topics: Population & Wastewater. The author has an hindex of 13, co-authored 45 publications receiving 5678 citations.

Papers
More filters
Journal ArticleDOI

Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2

Evan Bolyen, +123 more
- 01 Aug 2019 - 
TL;DR: QIIME 2 development was primarily funded by NSF Awards 1565100 to J.G.C. and R.K.P. and partial support was also provided by the following: grants NIH U54CA143925 and U54MD012388.
Posted ContentDOI

QIIME 2: Reproducible, interactive, scalable, and extensible microbiome data science

Evan Bolyen, +119 more
- 24 Oct 2018 - 
TL;DR: QIIME 2 provides new features that will drive the next generation of microbiome research, including interactive spatial and temporal analysis and visualization tools, support for metabolomics and shotgun metagenomics analysis, and automated data provenance tracking to ensure reproducible, transparent microbiome data science.
Journal ArticleDOI

Meta-analysis of gut microbiome studies identifies disease-specific and shared responses.

TL;DR: The MicrobiomeHD database, which includes 28 published case–control gut microbiome studies spanning ten diseases, is introduced, and a cross-disease meta-analysis of these studies using standardized methods finds consistent patterns characterizing disease-associated microbiome changes.
Journal ArticleDOI

SARS-CoV-2 Titers in Wastewater Are Higher than Expected from Clinically Confirmed Cases

TL;DR: A laboratory protocol to quantify viral titers in raw sewage via qPCR analysis and validate results with sequencing analysis suggests that the number of positive cases estimated from wastewater viral titer is orders of magnitude greater than the numberof confirmed clinical cases and therefore may significantly impact efforts to understand the case fatality rate and progression of disease.